Website & contact details
- Website
Cresset Biomolecular Discovery Limited
- Incorporated
- 31 January 2001 (25 years)
- Industry
- Business and domestic software development (62012) Other research and experimental development on natural sciences and engineering (72190)
- Directors
- Dale Curtis Jr.
- Owned by
- Sep VI L.P.
- Accounts type
- Group
- Region
- East of England
- Address
- New Cambridge HouseBassingbourn RoadLitlingtonSG8 0SS
Filing status
- Accounts due
- 31 December 2026
- Last accounts
- 31 March 2025
- Conf. stmt due
- 14 October 2027
- Last conf. stmt
- 30 September 2026
Charges
- Total
- 2
- Outstanding
- 0
- Part satisfied
- 0
- Satisfied
- 2
Officers 8 active
Officer details are public data from the Companies House register.
Curtis Jr, Dale
Director · Appointed 1 May 2024
American
Born October 1976 (50)
Director · Appointed 15 September 2022
British
Born June 1988 (38)
Director · Appointed 14 October 2021
British
Born January 1971 (55)
Scutt, Rebecca Jane
Director · Appointed 13 February 2020
British
Born September 1974 (52)
Scutt, Rebecca
Secretary · Appointed 4 May 2017
Cheeseright, Timothy John, Dr
Director · Appointed 17 April 2013
British
Born August 1966 (60)
Mackey, Mark Denis, Dr
Director · Appointed 16 March 2011
Australian
Born August 1971 (55)
Scoffin, Robert Arthur, Dr
Director · Appointed 19 April 2010
British
Born January 1966 (60)
Officer history (17 former)
23 March 2026
14 May 2024
1 May 2024
Appointed Curtis Jr, Dale as Director
11 April 2023
15 September 2022
14 October 2021
13 February 2020
Appointed Scutt, Rebecca Jane as Director
16 December 2019
Resigned Vinter, Jeremy Gilbert, Dr as Director
4 May 2017
Appointed Scutt, Rebecca as Secretary
4 May 2017
Resigned Vinter, Jeremy Gilbert, Dr as Secretary
17 April 2013
17 April 2013
Appointed Cheeseright, Timothy John, Dr as Director
10 April 2013
8 April 2013
26 March 2013
8 September 2011
16 March 2011
Appointed Mackey, Mark Denis, Dr as Director
1 January 2011
19 April 2010
Appointed Scoffin, Robert Arthur, Dr as Director
14 July 2009
1 October 2008
27 August 2008
Appointed Vinter, Jeremy Gilbert, Dr as Secretary
27 August 2008
Resigned Rose, Valerie Sarah, Dr as Director
27 August 2008
Resigned Rose, Valerie Sarah, Dr as Secretary
1 May 2007
Appointed Rose, Valerie Sarah, Dr as Director
20 December 2006
25 July 2006
Resigned Halls, Raymond David as Director
25 July 2006
Resigned Rose, Valerie Sarah, Dr as Director
25 July 2006
Resigned Hillier, Paul Ashley as Director
1 September 2005
Appointed Rose, Valerie Sarah, Dr as Secretary
31 August 2005
Resigned Halls, Raymond David as Secretary
20 July 2004
Appointed Rose, Valerie Sarah, Dr as Director
1 May 2004
10 September 2002
Resigned Ashworth, Philip Anthony, Dr as Director
1 September 2002
18 July 2002
Resigned Lamont, Alan Gordon as Director
14 November 2001
Appointed Lamont, Alan Gordon as Director
31 January 2001
Appointed Halls, Raymond David as Director
31 January 2001
Appointed Hillier, Paul Ashley as Director
31 January 2001
Appointed Halls, Raymond David as Secretary
31 January 2001
Appointed Vinter, Jeremy Gilbert, Dr as Director
31 January 2001
Appointed Ashworth, Philip Anthony, Dr as Director
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Sep VI L.P.
Corporate entity · Notified 15 September 2022
Owns 25–50% of shares
Holds 25–50% of voting rights
Limited Partnership
Holdings 1
Companies where Cresset Biomolecular Discovery Limited is registered as a person with significant control
Owns 25–50% of shares
Active
Former controllers (1)
8 December 2020
Ceased Jeremy Gilbert Vinter — Owns 25–50% of shares
Financials
Figures from 2022 accounts. Newer accounts, made up to 31 March 2025, are filed but not read yet. See them on Companies House
- Net Assets
- £2,106,901
- up £713,874 (51%)
- Cash
- £2,019,479
- up £625,786 (45%)
- Employees
- 46
- up 15 (48%)
- Debt Ratio
- 65%
- Current Ratio
- 1.2x
Balance sheet detail
| 2022 | |
|---|---|
| Fixed Assets | £1,389,542 |
| Current Assets | £4,628,779 |
| Cash | £2,019,479 |
| Creditors (< 1 year) | £3,892,723 |
| Creditors (> 1 year) | £18,697 |
| Net Current Assets | £736,056 |
| Net Assets | £2,106,901 |
| Shareholder Funds | £2,106,901 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 17 June 2026 | Statement of capital following an allotment of shares | |||
| 21 May 2026 | Statement of capital following an allotment of shares | |||
| 23 March 2026 | Termination of appointment of a director | |||
| 19 December 2025 | Group of companies' accounts | 31 March 2025 | ||
| 18 December 2025 | Statement of capital following an allotment of shares |
Some other companies at this address
Other companies in this industry
Manchester
Warrington
London
Manchester
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →